A systematic review was used to identify randomized controlled trials (RCTs) and observational epidemiologic studies (OBSs) that examined protein intake consistent with either the US RDA (0.8 g/kg or 10-15% of energy) or a higher protein intake (≥20% but <35% of energy or ≥10% higher than a comparison intake) and reported measures of kidney function. Studies (n = 26) of healthy, free-living adults (>18 y old) with or without metabolic disease risk factors were included. Studies of subjects with overt disease, such as chronic kidney, end-stage renal disease, cancer, or organ transplant, were excluded. The most commonly reported variable was glomerular filtration rate (GFR), with 13 RCTs comparing GFRs obtained with normal and higher protein intakes. Most (n = 8), but not all (n = 5), RCTs reported significantly higher GFRs in response to increased protein intake, and all rates were consistent with normal kidney function in healthy adults. The evidence from the current review is limited and inconsistent with regard to the role of protein intake and the risk of kidney stones. Increased protein intake had little or no effect on blood markers of kidney function. Evidence reported here suggests that protein intake above the US RDA has no adverse effect on blood pressure. All included studies were of moderate to high risk of bias and, with the exception of 2 included cohorts, were limited in duration (i.e. <6 mo). Data in the current review are insufficient to determine if increased protein intake from a particular source, i.e., plant or animal, influences kidney health outcomes. These data further indicate that, at least in the short term, higher protein intake within the range of recommended intakes for protein is consistent with normal kidney function in healthy individuals. Adv Nutr 2018;9:404-418.
Introduction
The US RDA for adult men and women is 0.80 g · kg −1 · d −1 of good-quality protein, based on a calculated protein digestibility corrected amino acid score (1) . Similarly, the WHO recommends 0.83 g protein · kg −1 · d −1 for adults Financial and material support for the writing of this manuscript has been provided by the Beef Checkoff. Technical experts employed by the funding source participated in the conception and design of the manuscript and provided critical review.
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(2). A 2012 report (3) from the European Food Safety Authority established a Population Reference Intake for protein of 0.83 g · kg −1 · d −1 for adult men and women of all ages. The US acceptable macronutrient distribution range (AMDR) for protein, aimed at chronic disease risk reduction, is 10-35% of caloric intake and is estimated to equate to 1.05-3.67 g · kg −1 · d −1 based on reference body weights for men and women (1, 4) . The current estimated average protein intake in the United States is 165 g/d (5) . Although individuals with chronic kidney disease are advised to limit protein intake, multiple global and national evidence-based reviews designed to establish DRIs for healthy populations have found insufficient evidence to establish an upper limit (UL) for protein intake (1) (2) (3) 6) . Despite insufficient evidence to establish a UL, evidence from animal models and individuals with chronic kidney disease have led to the hypothesis that prolonged intake of higher-protein diets could ultimately compromise kidney health and diminish renal function in healthy individuals (7) . Several lines of evidence, including adapative renal hyperfiltration without negative consequence during pregnancy and after unilateral nephectromy, suggest otherwise (7) . Nevertheless, dietary advice for healthy adults to limit protein intake to the RDA, rather than increase protein intake within the AMDR, even in circumstances when increased protein intake is warranted, persists and may stem at least in part from concerns regarding long-term kidney health (4) .
As a wide range of protein intake levels appear acceptable based on current DRI levels, this review was designed to examine published literature investigating the relation of protein intake and indicators of kidney function in healthy adults, with the purpose of understanding whether levels of intake above the currently established US RDA of 0.8 g/kg body weight, but within the AMDR, are consistent with normal kidney health and function. Glomerular filtration rate (GFR) measures filtration rates of normally functioning nephrons, and is thought to provide the best index of normal kidney function (8) . To ensure that studies included in the current review were of healthy adults, only studies reporting results of populations with normal GFR of ≥90 mL · min −1 · 1.73 m −2 were reviewed.
Methods

Information sources
To identify relevant studies, a literature search was conducted with PubMed up until 9 August 2017. Supplementary literature searches included examining the reference lists of all relevant studies, pertinent review articles, and meta-analyses.
Search strategy
Search terms related to studies of protein intake and kidney health and function were combined in the following strategy: ( Additionally, PubMed filters were applied to limit results to human studies published in English.
Eligibility criteria
Included studies were randomized controlled trials (RCTs) and observational epidemiologic studies (OBSs) that examined protein intake consistent with either the US RDA for protein (0.8 g · kg body weight −1 · d −1 or 10-15% of energy) or a higher protein intake (≥20% of energy or ≥10% than a comparison intake), and reported measures of kidney function. Studies of healthy, free-living adults (>18 y old) with or without metabolic disease risk factors, such as elevated cholesterol, diabetes, high blood pressure, or obesity, were included. Studies of subjects with overt disease, such as chronic kidney disease, end-stage renal disease, cancer, organ transplant, etc., were excluded. Studies were excluded for the following reasons: 1) if they were designed to examine outcomes in response to protein type but not protein quantity, i.e., protein source comparison only; 2) if they supplemented protein in the form of full isoflavone soy, i.e., isoflavones not removed or minimized; 3) if they were acute feeding studies of ≤24 h; 4) if they were of populations with GFR <90 or albumin excretion rate (AER) >30 or diagnosis of end-stage renal disease; 5) if they were designed to provide or included subjects with protein intake in excess of 35% of energy or 2.5 g/kg and had no study arm with a lower intake value or protein intake <0.66 g/kg; 6) if they were designed for weight loss or conducted in a manner where subjects did not maintain energy balance; 7) if they were designed to provide protein as a purified amino acid bolus or administered intravenously; 8) if they allowed concomitant intervention with drugs or supplements that influence body weight; 9) if they comprised letters, abstracts, case reports, case series, position statements, hypotheses, study designs, conference proceedings, prevalence surveys; 10) if they were published in a language other than English; 11) if they were conducted in a population nonrepresentative of the general healthy adult population, i.e., pediatric, pregnant and nursing women, vegan-only studies (vegetarians studies included), subjects with significant disease process, i.e., renal disease, cancer, etc., or protein-energy malnutrition; 12) if they were animal or in vitro studies.
Study selection
Level I screening included a review of all titles and abstracts to check these against eligibility criteria. Full-text publications of any studies not eliminated at Level I were retrieved for complete review at Level II screening, which involved reading the full-text publication to determine that all eliqibility criteria were met and no exclusion criteria were applicable. Study selection was completed by a combination of 1 (Level I) or 2 reviewers (Level II). Discrepencies were resolved via discussion among all authors.
Data collection process
A data extraction sheet was created in Excel to capture all data of interest from intervention trials. One independent extractor completed data extraction for all studies. The following list of data items (not exhaustive) was extracted from published intervention trials: 1) study identification details [including study first author; year of study publication; title of publication (first 5 words); country where study was conducted; study type (RCT or OBS); double-blind (yes or no)]; 2) subject baseline demographics; 3) intervention details [including protein source; level of protein intake at baseline and incremental supplementation; duration of supplementation (days)]; 4) dietary details (including baseline diet assessment method; baseline diet information); 5) data details (including number of completed subjects in each group; number of enrolled subjects; 6) outcome assessment method; 7) outcome unit as reported by author; 8) standard deviations (recorded if reported by author or calculated from available data); 9) pre-and poststudy outcome means.
Protein intake
In order to make the studies more comparable, protein intake was recorded as grams per day, grams per kilogram per day, and percentage of total energy. Data were taken directly as reported by the author where possible, or calculated from data provided by the authors in the publication when possible.
Bias assessment
For RCTs, bias was assessed with the Cochrane Bias Assessment Tool (9) . For prospective cohort studies, bias was assessed with the Newcastle-Ottawa scale (10) . To assess bias in cross-sectional studies, an adapted version of the NewcastleOttawa scale was used (11) . Bias assessments were completed by 2 individuals, results were reviewed collectively, and discrepancies resolved via discussion.
Results
Search results
The Pub Med search yielded 564 publications. An additional 11 publications were discovered via review of pertinent publication bibliographies for a total of 575 publications screened at Level I (i.e., title and abstract). In total, 482 publications were excluded based on initial (Level I) screening of abstracts and titles (Figure 1) . The most common reason for exclusion of studies at Level I screening was ineligible subject population. Full-text publications of 94 studies were retrieved for complete full-text review at Level II. Sixty-eight studies were excluded at Level II. Citations for studies excluded at Level II with reason for exclusion are listed in Supplemental Table 1 . Although some trials and observational studies had more than one reason for exclusion, each study was classified into only one exclusion category. A total of 26 studies (18 RCTs and 8 OBSs) were included. For ease of discussion, the studies were grouped according to study type (RCT or OBS) and reported outcomes.
Observational studies
Cross-sectional. Six cross-sectional studies (12) (13) (14) (15) (16) (17) of moderate to high risk of bias met our inclusion criteria ( Table 1, Supplemental Tables 2 and 3) . Two prospective cohorts (18, 19) of moderate to low risk of bias also met our inclusion criteria ( Table 2, Supplemental Table 4 ). Ausman et al. (12) reported a cross-sectional study of a small population of women with varying levels and types of dietary protein intake all in excess of the US RDA. Generally speaking, omnivores had higher total protein intake (1.3 g/kg) than vegans (0.96 g/kg), but all outcomes remained within normal limits (WNL) for both groups (Table 1). One study (15) reported differences in urinary and blood outcomes related to kidney function in body builders compared with other athletes. During a 30-d follow-up, estimated protein intake of up to nearly 2.0 g/kg protein intake (protein source not reported) did not appear to negatively influence markers of kidney function in athletes with all outcomes remaining normal (Supplemental Table 2 ) (15). Teo et al. (16) found no association between protein intake (0.97 ± 0.28 g · kg
) and GFR (measured) or serum creatinine in a small sample of healthy Asian adults (Table 1) . Ogna et al. (14) found a significant association between creatinine clearance (WNL), but no other kidney function parameter, including estimated glomerular filtration rate (eGFR), in healthy Swiss adults with an average intake of 1.05 g protein/kg ( Table 1) . Observation of healthy Norwegian adults failed to find an association between protein intake and serum uric acid (17) . Finally, Berryman et al. (13) reported on the largest cross-sectional sample of adults and kidney-related outcomes, further delineated according to protein source (i.e. total, animal, dairy, plant). eGFR for all levels of intake (≤1.45 g/kg) was consistent with normal kidney function, and was positively associated with plant and total protein, although this association was nonsignificant after adjustment for common demographic/anthropometric variables, as well as carbohydrate, total fat, saturated fat, and fiber intake. Similarly, plant protein was positively associated with blood pressure, but this observation was also attenuated after adjustment for confounding factors. All protein types and levels were associated with creatinine levels, but after adjustment the association was attenuated for all but total protein. The authors found no evidence of an association between GFR, blood urea nitrogen and creatinine levels with increasing consumption of various protein types (Table 1) (13).
Prospective cohort. The prospective cohort studies (Table   2 ) (18, 19) included in this review provide limited evidence of an association between level or protein source, and risk of kidney disease. Herber-Gast et al. (18) reported a significant association between increased low-fat dairy and maintenance of normal eGFR in healthy Dutch adults during 15 y of follow-up. No association between total and animal protein and incidence of kidney disease was noted during 21 y of follow-up in a population of US adults, whereas vegetable protein was associated with a significant 11% decreased risk of kidney disease. While neither study (18, 19) provided information sufficient to calculate grams per kilogram protein intake, both reported protein intake levels consistent with ≥10% of energy, which is consistent with ≥0.8 g/kg based on reference body weights for men and women.
Randomized controlled trials
The majority of included clinical trials were of moderate to high risk of bias (Supplemental Figure 1) , and were conducted in healthy subjects (n = 10) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) or those with either mild hypertension (n = 2), hyperlipidemia (n = 2) (30, 31), or type 2 diabetes without microalbuminuria (n = 4) (32) (33) (34) (35) . The majority of studies were crossover design of ≥4 d in duration. While many (n = 7) studies exceeded 1 mo in duration, no studies were conducted over a period ≥6 mo. Five studies were >1 wk, but <1 mo and 6 studies lasted between 4 and 7 d. Most studies had a small sample size (≤60 subjects; mean = 16). Only 2 studies (36, 37) exceeded 100 subjects. Studies were fairly evenly distributed between those of both men and women and single-sex studies, and those enrolling younger (≤30 y old) or older (40-70 y old) subjects. The majority of studies assessed kidney function by measuring the effect of protein intake on a variety of outcomes including GFR with a fairly even distribution of those reporting eGFR and measured GFR. Several studies (n = 9) also reported the influence of protein intake on blood pressure; a few studies (n = 3) reported hormone-related variables.
Effect of protein intake on blood pressure. In all studies examining blood pressure outcomes (Supplemental Table 5 ), except one (32), the normal/low-protein group provided ≥0.8 g · kg
for the higher-protein group. One study (32) compared a diet substituting chicken for red meat (1.3 g/kg) with a low-protein diet (0.66 g/kg) in healthy diabetic subjects on various outcomes. The majority of studies supplemented protein either by the addition of animal protein alone (meat and dairy products) or a combination of animal and vegetable protein. Two studies (30, 33) 45; blood urea nitrogen: 2.5-8.0 mmol/L; creatinine clearance: 75-125 mL/min; serum creatinine-adult men: 70-120 µmol/L; adult women: 50-90 µmol/L; serum uric acid: 180-420 µmol/L; urinary volume: 800-2000 mL. NS: P ≥ 0.05. eGFR, estimated glomerular filtration rate; GFR, glomerular filration rate; LOV, lacto-ovo vegetarian; N, normal; NR, not reported; OV, omnivore; Q, quartile; V, vegan; WNL, within normal limits. 2 Values reported as means by original publication. 3 Calculated from data provided in study publication. 4 Reported for deciles 1, 5, and 10. level or source, the majority of studies reported no significant effect of diet on blood pressure outcomes (Supplemental Table 5 ).
The only studies to report an influence of protein intake on blood pressure were the 2 largest, representing the Dietary Approaches to Stop Hypertension Trial (DASH) (n = 378) (36) and the Optimal Macronutrient Intake Trial to Prevent Heart Disease (OmniHeart) (n = 164) (37), which both found that higher protein intake was associated with lower blood pressure in subjects with mild hypertension. Specifically, Jursacheck et al. (37) compared 3 sodiummatched diets (2300 mg/d) designed to provide higher carbohydrate, unsaturated fat, or protein. The carbohydrate and unsaturated fat diets provided 15% of energy from protein, whereas the protein diet provided 25% of energy as protein and resulted in the lowest blood pressure at study end. Similarly, Jacobs et al. (36) compared a normal diet (13.8% of energy), a fruit and vegetable diet (15.1%), and a DASH diet (17.9%) with similar sodium levels (1314-1354 mg/1000 kcal) in hypertensive men and women. Participants consuming the DASH diet consumed the highest level of protein and exhibited the lowest blood pressure at study end.
Urinary measures of kidney health and function. Studies examining urinary measures related to kidney health ( Table 3 ) typically compared normal/control protein intakes of 0.7-1.5 g/kg with higher protein intakes of 1.8-2.5 g/kg daily. Four studies did not report the source of added protein.
Of the studies reporting protein source, half reported supplementing protein intake with animal protein, either as a combination of meat and dairy or as poultry and fish, compared with a combination of plant and animal protein or plant protein only. Only 2 studies (32, 26) reported urinary measures in response to either plant or animal protein.
The most commonly reported variable of kidney function was measured (as opposed to estimated) GFR, with 13 studies comparing GFRs obtained with normal and higher protein intakes. Most (n = 8), but not all (n = 5), studies reported significantly higher GFR in response to increased protein intake. No obvious pattern emerged regarding those reporting increased GFR compared with those that did not. Those studies that did not observe increased GFR following increased protein intake were mixed with regard to gender distribution, length of study, source of protein, and whether or not GFR was measured or estimated. Among studies reporting an increased GFR in response to protein intake, rates remained (20) (21) (22) . Studies reporting the highest GFR were mostly of limited duration (1 wk), in young subjects (aged 21-26 y), and were small in size (≤24 subjects). It is likely that the age of the subjects contributed most to the observation of the high GFR in these studies (rather than duration or sample size) as GFR is influenced by age, and higher in young, compared with older adults (8) . Among studies of limited duration that failed to observe an increased GFR, some used diets formulated to have equal levels of sodium intake (23, 25, 26) .
Two studies (32, 34) in the current review measured GFR in healthy diabetic subjects (with normal urinary albumin concentrations) in response to increased protein intake up 1.4 g · kg −1 · d −1 . While providing 1.2 g protein/kg for 4 mo to older (60-68 y) diabetic men and women had no effect on GFR (34), providing 1.4 g/kg to older (47-69 y) diabetic men and women for 4 wk compared with a low-protein diet (0.66 g/kg) significantly increased GFR (from 113 to 93.8 mL · min -1 · 1.73 m -2 ) (32). Two studies (35, 33) in the current review reported urinary glucose concentrations in older type 2 diabetics in response to elevated protein intake. One study (35) found no effect of protein intake on urinary glucose, but the other (33) reported a significant reduction in urinary glucose in response to a diet designed to provide 30% of energy as protein compared with 15%.
Increased risk of kidney stone formation is an additional concern when considering consumption of protein above the US RDA (38, 39) . Six studies in the current review examined factors related to kidney stone formation. Blood markers of kidney health. Ten studies measured a variety of blood markers of kidney function in response to protein intakes (Supplemental Table 6 ) of 0.7-1.5 g/kg up to higher protein intakes of 1.8-2.5 g/kg daily. Studies were mostly small and conducted with healthy subjects or those with mild hypertension or type 2 diabetes, but with normal kidney function. No studies directly compared plant and animal source protein for effects on blood measures of kidney function. No pattern of abnormality among blood variables, suggestive of adverse effects of increased protein intake, was observed. Generally speaking, increased protein intake had little or no effect on blood markers of kidney function. When changes were evident, for the most part, they remained WNL. One exception is provided by the study of 5 young men participating in a 12-wk crossover study comparing "low" (0.8 g/kg), "moderate" (1.8 g/kg), and "high" (3.6 g/kg) protein intake. In this study, protein intake of 3.6 g/kg significantly increased blood urea nitrogen concentrations beyond the UL of the normal range (i.e. 21.2 in subjects compared with 20 mg/dL UL of normal). Given the very small sample size, it is difficult to know if the observed increase is real or an artifact.
Discussion
The relation between dietary protein intake and systemic blood pressure is an important consideration because certain micronutrients known to impact blood pressure (e.g. sodium, potassium, calcium) may also increase with increased protein consumption (7) . In addition, elevated blood pressure is a prevalent disease risk factor with 31% of Americans hypertensive, 30% prehypertensive, and ∼20% hypertensive, yet unaware of their status (40, 41) . Evidence indicates only 47% of those with hypertension are adequately controlled (40) . Prior research shows that diet and lifestyle modifications, including physical activity, sodium reduction, and fish oil supplementation, can reduce blood pressure, enhance antihypertensive drug efficacy, and decrease cardiovascular disease risk (42) . Evidence reported here suggests that protein intake above the US RDA has no adverse effect on blood pressure and may, along with modified sodium intake, help reduce blood pressure. Importantly, our review limited studies of protein intake and blood pressure to only those designed to also measure kidney function. A broader evidence base relating blood pressure to protein intake exists, however. For example, meta-analyses of cross-sectional studies consistently report an inverse association between dietary protein intake and blood pressure, although neither analysis considered the potential impact of displacement of highersodium foods by increased protein intake (43, 44) . Results from prospective cohorts are limited (43) and suggest either no association between blood pressure and protein intake (44) , or an inverse association observed after ≤7 y of follow-up (43) and, in elderly subjects, a positive association between protein intake and risk of hypertension (45) . Evidence from RCTs also supports an inverse relation between dietary protein and blood pressure, particularly when protein replaces carbohydrate, in both healthy subjects and those with type 2 diabetes (46, 47) . Evidence further suggests that blood pressure reductions are observed regardless of source, with animal and plant proteins resulting in similar reductions (46) . Although the mechanism by which protein intake lowers blood pressure is not fully elucidated, hypotheses regarding the observation include adaptive changes in kidney function, particularly increased GFR, and effects of individual amino acids on nitric oxide production (2, 48) .
Increased GFR in response to high protein intake is well documented and is believed to be due to increased generation of nitric oxide and increased production of vasoactive kinins (49) . The significance of increased GFR in healthy populations is debatable. It has been hypothesized that GFR >125 mL · min -1 · 1.73 m -2 should be considered "hyperfiltration" and that, over a prolonged period, this higher rate might contribute to the onset and progression of chronic kidney disease (49) . Schwingshackl and Hoffman (50) recently conducted a meta-analysis of high-or low-protein RCTs designed for weight loss or weight maintenance. While weightloss studies and those ≤24 h in duration were excluded from the current review, 30% of the studies of those reviewed by Schwingshackl and Hoffman overlap with the current review. Consistent with our observations, Schwingshackl and Hoffman report an increased mean difference in GFR with higher than with lower protein (+7. 18 ). The authors concluded that "although the mean change in eGFR in the LCD group was greater than that in the control group, the difference was very low. Therefore, the clinical significance of LCD on renal function might not be great. However, this meta-analysis showed that LCD and the corresponding high-protein diet was not harmful for renal function in overweight and obese individuals without renal dysfunction."
One of the studies included in the current review (29) compared responses of young healthy subjects (mean age 24 y) with those of healthy older subjects (mean age 70 y) to protein intake levels up to twice the US RDA in older adults, and ≤2.0 g/kg in younger adults. GFR declines with age, as does the ability to further increase GFR in response to a high protein load (49) . GFR of younger adults increased significantly within the normal range, but older adults did not respond with increased GFR and, in fact, GFR was lower at the end of the study period although the change was nonsignificant (P = 0.13). Given the limited duration of the study (10 d) , it is impossible to determine if the nonsignificant change in GFR in older adults would be sustained or if GFR would increase were the study prolonged. Data such as these have led to concerns that elderly subjects may be at greater risk of kidney disease in response to higher levels of protein intake (52) . However, recent cross-sectional data, although not meeting eligibility criteria for the current review, suggest otherwise. Beasley et al. (53) examined the association between dietary protein intake and GFR in elderly subjects participating in the Cardiovascular Health Study. Consistent with age, GFR in all participants was low (<75 mL · min -1 · 1.73 m -2 estimated), but interestingly, when stratified according to protein intake, little difference in GFR was observed between the highest (1.63 g/kg) and lowest (1.00 g/kg) quartiles of protein intake. In fact, the maximum GFR (74 ± 18 mL · min -1 · 1.73 m -2 ) was found in the highest quartile of protein intake compared with the GFR of 71 ± 18 mL · min -1 · 1.73 m -2 found in the lowest quartile of protein intake (P value for linear trend <0.05). Given the importance of protein intake to the maintenance of body protein with age (54), additional research is needed to determine if healthy older adults are at increased risk for kidney disease in response to dietary protein intake.
Based on these limited data, it would appear that type 2 diabetics with normal kidney function may increase protein intake above the RDA, ≤1.2 g/kg, without negative consequence to GFR.
Additional research is needed to elucidate the role of protein intake in glucose homeostasis and maintenance of normal kidney function in older type 2 diabetics.
The evidence from the current review is limited and inconsistent, and cannot be used to draw a conclusion regarding increased protein intake and risk of kidney stones. Similarly, a recent evidence-based review used to establish protein intake recommendations for Norway found the evidence for an association between protein intake and kidney stone formation to be "inconclusive" (6) .
Evidence limitations and future research recommendations
It is important to put the current review in perspective regarding level of protein intake. The current review considers "higher" protein intakes, but does not consider studies of "excessive" protein intake, i.e., in excess of the AMDR of 35% of total energy (55, 56) . There is limited evidence regarding the long-term consumption of excessive protein; what there is, mainly comes from studies of endurance and strength athletes (56) . Nonetheless, after review of renal health and other outcomes in response to excessive protein intake in athletes, Tipton (56) concluded: "This review is in no way intended to advocate high protein intakes for athletes and exercisers. Yet, the risks of high protein intake seem to be minimal for otherwise healthy athletes."
Conclusions drawn from the evidence reviewed herein regarding "higher" protein intake must also be considered with a degree of caution as the majority of studies were found to be of moderate to high risk of bias. While the findings were generally consistent across the included studies, similar consistency from more rigorously conducted trials would increase confidence. It is recommended that future studies in healthy subjects strive to improve study design factors such as randomization and blinding of subjects and personnel to reduce risk of bias results.
With the exception of the 2 included cohort trials, the studies included here were of limited duration, with none exceeding 6 mo. Thus, the long-term consequence of healthy individuals increasing their protein intake to up to twice the US RDA (or within the higher bound of the AMDR) remains somewhat unexplored, although several global and national evidence-based reviews used to establish DRIs have failed to find evidence sufficient to establish a UL (1-3, 6 ). The unavailability of evidence need to establish a UL, however, cannot be considered the same as lack of evidence of harm. Thus, in an effort to confirm the safety of higher-protein diets for long-term consumption by healthy individuals, RCTs of longer duration are needed to corroborate the observations reported in long-term cohort studies.
Similarly, the evidence base for increased risk of kidney stone formation in healthy individuals consuming higherprotein diets is limited. Measurement of urinary pH is a simple indicator of increased kidney stone risk that could be added to both RCTs and OBSs with limited effort and expense. Finally, evidence regarding kidney function in type 2 diabetics with normal kidney function is limited, so it is difficult to confirm that consuming higher-protein diets is without adverse consequence in this population.
Conclusions
The role of protein in kidney health and function is debated each time recommendations for protein intake are evaluated. Based on the evidence reviewed herein, higher protein intake, at least within the short term, and within the range of DRIs, is consistent with normal kidney function in healthy individuals.
